EDNRB and leukemia: Interestingly, EDNRB was previously described to be methylated in numerous tumour entities, such as lung, colon, prostate, bladder, kidney, liver, oesophageal, nasopharyngeal cancer and leukemia [37-45], but to the authors' knowledge, never in gynaecological tumours.